Key facts
- Summus Global’s last known valuation is $226.5M (Apr 2026).
- It has raised $96.7M across 5 recorded rounds; the latest was Early Stage VC ($20.0M) in Mar 2026.
- Notable investors include Teamworthy Group, Sator Grove Holdings, Savoy Capital (Texas), ArgyleRoad, Danaher — 7 tracked in total.
- Summus Global has filed 4 Form Ds with the SEC since 2021, most recently Aug 2025 ($7.5M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Summus Global
Funding rounds
5 roundsAbout Summus Global
Operator of a virtual specialist platform intended to provide an elevated healthcare experience. The company's platform provides access to medical expertise and partners with companies to provide healthcare access to their employees, enabling families with access to a network of top specialists across all health questions and stages of care.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2015
- Employees
- 119
- Website
- summusglobal.com/
- Ownership
- Privately Held (backing)
Summus Global doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Summus Global shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Summus Global in its N-PORT filings yet. We sweep new filings monthly.